Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - MELINTA THERAPEUTICS, INC. /NEW/ | mlnt-ex322_10.htm |
| EX-32.1 - EX-32.1 - MELINTA THERAPEUTICS, INC. /NEW/ | mlnt-ex321_9.htm |
| EX-31.2 - EX-31.2 - MELINTA THERAPEUTICS, INC. /NEW/ | mlnt-ex312_6.htm |
| EX-31.1 - EX-31.1 - MELINTA THERAPEUTICS, INC. /NEW/ | mlnt-ex311_8.htm |
| EX-23.1 - EX-23.1 - MELINTA THERAPEUTICS, INC. /NEW/ | mlnt-ex231_12.htm |
| 10-K - MLNT 2017 10-K - MELINTA THERAPEUTICS, INC. /NEW/ | mlnt-10k_20171231.htm |
Exhibit 21.1
Subsidiaries of the Company
|
|
|
|
|
Subsidiary |
|
Jurisdiction of Incorporation |
|
Cempra Pharmaceuticals, Inc. |
|
Delaware |
|
CEM-102 Pharmaceuticals, Inc. |
|
Delaware |
|
Melinta Subsidiary Corp. |
|
Delaware |
|
Rempex Pharmaceuticals, Inc. |
|
Delaware |
|
Targanta Therapeutics Corporation |
|
Delaware |
|
Rib-X Therapeutics Ltd |
|
United Kingdom |
|
Rempex London Limited |
|
United Kingdom |
|
Rempex Australia Pty Ltd. |
|
Australia |